AU500250B2 - Influenza vaccine - Google Patents

Influenza vaccine

Info

Publication number
AU500250B2
AU500250B2 AU77305/75A AU7730575A AU500250B2 AU 500250 B2 AU500250 B2 AU 500250B2 AU 77305/75 A AU77305/75 A AU 77305/75A AU 7730575 A AU7730575 A AU 7730575A AU 500250 B2 AU500250 B2 AU 500250B2
Authority
AU
Australia
Prior art keywords
influenza vaccine
influenza
vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
AU77305/75A
Other languages
English (en)
Other versions
AU7730575A (en
Inventor
H. & Schmidt G Bachmayer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duphar International Research BV
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of AU7730575A publication Critical patent/AU7730575A/en
Application granted granted Critical
Publication of AU500250B2 publication Critical patent/AU500250B2/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
AU77305/75A 1974-01-14 1975-01-14 Influenza vaccine Expired AU500250B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (no) 1974-01-14 1974-01-14
GHGH447/74 1974-01-14

Publications (2)

Publication Number Publication Date
AU7730575A AU7730575A (en) 1976-07-15
AU500250B2 true AU500250B2 (en) 1979-05-17

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
AU77305/75A Expired AU500250B2 (en) 1974-01-14 1975-01-14 Influenza vaccine

Country Status (27)

Country Link
JP (2) JPS58407B2 (no)
AT (1) AT345449B (no)
AU (1) AU500250B2 (no)
BE (1) BE824372A (no)
CA (1) CA1049406A (no)
CH (1) CH589453A5 (no)
CS (1) CS191254B2 (no)
DD (1) DD116239A5 (no)
DE (1) DE2500785B2 (no)
DK (1) DK140003B (no)
ES (1) ES433759A1 (no)
FI (1) FI54053C (no)
FR (1) FR2257305B1 (no)
GB (1) GB1498261A (no)
HK (1) HK56380A (no)
HU (1) HU173920B (no)
IE (1) IE40794B1 (no)
IL (1) IL46426A (no)
MY (1) MY8100204A (no)
NL (1) NL166622C (no)
NO (1) NO143128C (no)
PH (1) PH14458A (no)
PL (1) PL93689B1 (no)
SE (1) SE427238B (no)
SU (1) SU616997A3 (no)
YU (1) YU41289B (no)
ZA (1) ZA75259B (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (en) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccine containing B subunits of heat-labile enterotoxin (LTB) of Escherichia coli as an adjuvant
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
AU2006310171B2 (en) * 2005-11-01 2011-02-17 Seqirus UK Limited Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment
RU2496519C2 (ru) 2007-08-28 2013-10-27 Бакстер Интернэшнл Инк. Способ получения препарата, содержащего вирусные антигены, и применение препарата
JP6373376B2 (ja) 2013-11-15 2018-08-15 ノバルティス アーゲー 残留細胞培養不純物の除去

Also Published As

Publication number Publication date
DK140003C (no) 1979-10-29
MY8100204A (en) 1981-12-31
HU173920B (hu) 1979-09-28
GB1498261A (en) 1978-01-18
IL46426A0 (en) 1975-04-25
DK1475A (no) 1975-09-01
FR2257305A1 (no) 1975-08-08
FI54053B (fi) 1978-06-30
DE2500785A1 (de) 1975-07-31
DK140003B (da) 1979-06-05
NL166622C (nl) 1981-09-15
AT345449B (de) 1978-09-11
ATA21475A (de) 1978-01-15
IE40794B1 (en) 1979-08-15
CH589453A5 (no) 1977-07-15
CS191254B2 (en) 1979-06-29
YU41289B (en) 1987-02-28
AU7730575A (en) 1976-07-15
PL93689B1 (no) 1977-06-30
SU616997A3 (ru) 1978-07-25
NO143128B (no) 1980-09-15
PH14458A (en) 1981-07-29
DD116239A5 (no) 1975-11-12
JPS50100224A (no) 1975-08-08
NL7500301A (nl) 1975-07-16
FI54053C (fi) 1978-10-10
CA1049406A (en) 1979-02-27
DE2500785C3 (no) 1980-09-11
HK56380A (en) 1980-10-16
ES433759A1 (es) 1977-02-16
JPS58407B2 (ja) 1983-01-06
DE2500785B2 (de) 1980-01-03
NL166622B (nl) 1981-04-15
YU5875A (en) 1984-04-30
IL46426A (en) 1978-01-31
JPS56127319A (en) 1981-10-06
NO143128C (no) 1980-12-29
ZA75259B (en) 1976-08-25
BE824372A (fr) 1975-07-14
NO750031L (no) 1975-08-11
JPS6035326B2 (ja) 1985-08-14
FR2257305B1 (no) 1982-03-19
SE427238B (sv) 1983-03-21
FI750014A (no) 1975-07-15
SE7500130L (no) 1975-07-15
IE40794L (en) 1975-07-14

Similar Documents

Publication Publication Date Title
CA1027416A (en) Wingfold configuration
AU497398B2 (en) Tetanus vaccine
AU467292B2 (en) Eye-bush
AU500250B2 (en) Influenza vaccine
CA1034136A (en) O-aminosulfonyglycolic anilides
AU498810B2 (en) Influenza vaccines
AU503647B2 (en) Antipregnancy vaccine
AU497239B2 (en) Parainfluenza virus vaccine
AU494738B2 (en) Virus subunit vaccine
AU485538B2 (en) Preparation ofa-6-deoxy-5-hydroxytetracycline
AU490363B2 (en) Scaffolding
AU480112B2 (en) Wingfold configuration
AU489628B2 (en) Cinnoline derivatives
AU494543B2 (en) Pharmaceutical formulations
AU486500B2 (en) Xeroradiographic member
AU8054075A (en) Preparation ofa-6-deoxy-5-hydroxytetracycline
AU482524B2 (en) Pyridoindoles
AU486206B2 (en) Triazolobenzodiazepines
AU482293B2 (en) 7-methoxycephalosporins
AU475114B2 (en) Arylalkylsulphoxides
AU482405B2 (en) Seco-prostaglandins
AU485075B2 (en) 2-nitroimidazoles
AU488320B2 (en) Polycycloanilines
AU489065B2 (en) B-cyproheptadine-n-oxide
AU484806B2 (en) Benzopyran-3-carbonitriles